Aim to evaluate the effects of blackcurrant supplementation on changes in gut microbiome and bone mass in adult women.
Postmenopausal bone loss is a primary contributor to osteoporosis and osteoporotic fractures in adult women. Overall goal of this project is to evaluate the effects of blackcurrant (BC) supplementation on changes in gut microbiome and bone mass in adult women. For this purpose, the investigators will conduct a pilot randomized placebo-controlled clinical trial with BC supplementation for 6 months in peri- and early postmenopausal women aged 45-60 years.
The primary endpoint will be lumbar spine bone mineral density (BMD); secondary endpoints will be gut microbial Firmicutes/Bacteroidetes (F/B) ratio. To delineate the underlying mechanisms of the action, changes in biomarkers for bone metabolism, bone-related immune and endocrine systemic biomarkers by BC supplementation will be measured in plasma and peripheral blood derived mononuclear cells.
The specific objectives of the study are to investigate the effects of BC extract on: 1) bone mass and bone remodeling markers; 2) changes in the gut microbiota abundance and composition, immune and endocrine biomarkers and their relationships with changes in bone mass.
The proposed study will provide novel insight into whether and how BC consumption reduces the risk of postmenopausal bone loss in adult women and will improve understanding of the clinical roles of gut microbiome in postmenopausal bone loss. Findings from this study will help increase awareness of the bone health promoting effect of BC and motivate increased production of BC and other berry products in response to the increasing consumer demand.
Condition | Postmenopausal osteoporosis, Gut Microbiota, Post-Menopausal Osteopenia, Post-Menopausal Osteoporosis, Osteoporosis |
---|---|
Treatment | blackcurrant (BC) extract |
Clinical Study Identifier | NCT04431960 |
Sponsor | University of Connecticut |
Last Modified on | 20 August 2021 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.